〇Takeshi Ogawa¹, Ryuta Tamano^1,2, Chang Cai¹, Arisa Katagiri¹, Motoaki Kawanabe^1,3 (1.ATR Cognitive Mechanisms Laboratories, Kyoto, Japan, 2.Neuroscience 2 Group, Drug Discovery & Disease Research Laboratories, Shionogi & Co., LTD., Osaka, Japan, 3.RIKEN-AIP, Kyoto, Japan)

〇Hirona Yamamoto^1,2,5, Takaoki Kasahara¹, Hyeon-Cheol Lee³, Takehiko Yokomizo³, Masashi Ikeda⁴, Nakao Iwata⁴, Atsushi Takata⁵, Kiyoto Kasai², Tadafumi Kato^6,1 (1.RIKEN Center for Brain Science, Molecular Dynamics of Mental Disorders, 2.Department of Neuropsychiatry, The University of Tokyo, Tokyo, Japan, 3.Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, Japan, 4.Department of Psychiatry, Fujita Health University School of Medicine, Tokyo , Japan., 5.RIKEN Center for Brain Science, Molecular Pathology of Psychiatric Disorders, 6.Department of Psychiatry & Behavioral Science Juntendo University Graduate School of Medicine)